Francois A Menard Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Francois A Menard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Francois A Menard. Francois A Menard is a SVP,Generics R&D in Actavis, Inc. ($ACT).
Address: 360 MT. KEMBLE AVENUE MORRISTOWN 07960 NJ
Companies in which Francois A Menard is an Insider
Allergan Finance LLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Francois A Menard: SVP,Generics R&D
Holdings: 39,860 shares
Latest Transaction: Mar 08 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Francois A Menard
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2011 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Payment of Exercise | F | 56.79 | 1,722 | 97,792 | 39,860 | 41.6 K to 39.9 K (-4.14 %) |
| Mar 04 2011 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Grant | A | 0.00 | 9,794 | 0 | 41,582 | 31.8 K to 41.6 K (+30.81 %) |
| Mar 16 2010 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Payment of Exercise | F | 41.37 | 843 | 34,875 | 31,788 | 32.6 K to 31.8 K (-2.58 %) |
| Feb 26 2010 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Grant | A | 0.00 | 11,456 | 0 | 32,631 | 21.2 K to 32.6 K (+54.10 %) |
| Feb 23 2010 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Payment of Exercise | F | 39.11 | 1,204 | 47,088 | 21,175 | 22.4 K to 21.2 K (-5.38 %) |
| Mar 06 2009 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Grant | A | 0.00 | 10,379 | 0 | 22,379 | 12 K to 22.4 K (+86.49 %) |
| Mar 14 2008 | ACT | Actavis, Inc. | Menard Francois A | SVP,Generics R&D | Grant | A | 0.00 | 5,200 | 0 | 12,000 | 6.8 K to 12 K (+76.47 %) |